All SPR experiments were performed using a Biacore T200 instrument operating at 25°C. Biotinylated HA was covalently immobilized on a streptavidin-coated, carboxymethylated dextran sensor surface (
SA chip, GE Healthcare). JNJ4796 was dissolved at 10mM in 100% DMSO and then diluted in the running buffer (20 mM PBS, 137 mM NaCl, 0.05%
P-20 surfactant, pH 7.4 (GE Healthcare), supplemented with 2% DMSO). Binding constants were obtained from a series of injections of JNJ4796 from 0.1 nM to 1 µM with a flow rate of 30 µl/min. Data from single-cycle kinetics were analyzed using BIAevaluation software. Base lines were adjusted to zero for all curves, and injection start times were aligned. The reference sensorgrams were subtracted from the experimental sensorgrams to yield curves representing specific binding followed by background subtraction (i.e. double-referencing). Binding kinetics was evaluated using a 1:1 binding model (Langmuir) to obtain association rate constants (k
a) and dissociation rate constants (k
d). Binding affinity (K
D) was estimated from the concentration dependence of the observed steady-state responses.
van Dongen M.J., Kadam R.U., Juraszek J., Lawson E., Brandenburg B., Schmitz F., Schepens W.B., Stoops B., van Diepen H.A., Jongeneelen M., Tang C., Vermond J., Real A.V., Blokland S., Garg D., Wu W., Goutier W., Lanckacker E., Klap J.M., Peeters D.C., Wu J., Buyck C., Jonckers T.H., Roymans D., Roevens P., Vogels R., Koudstaal W., Friesen R.H., Raboisson P., Dhanak D., Goudsmit J, & Wilson I.A. (2019). An orally active small molecule fusion inhibitor of influenza virus. Science (New York, N.Y.), 363(6431), eaar6221.